Review
doi: 10.1016/j.eururo.2004.01.012.
Molecular mechanisms of prostate cancer
Affiliations
- PMID: 15149739
- DOI: 10.1016/j.eururo.2004.01.012
Item in Clipboard
Review
Molecular mechanisms of prostate cancer
Eur Urol.
2004 Jun.
Abstract
During the last ten years our knowledge of genetic alterations in prostate cancer has significantly increased. For example, several chromosomal loci possibly harboring predisposing or somatically mutated genes have been suggested. Still, we lack the comprehensive molecular model for the development and progression of prostate cancer. Only a few genes have been found to be aberrant in a significant proportion of prostate cancer. These include GSTP1, PTEN, TP53, and AR. Thus, they are natural targets for new treatment strategies.
Similar articles
-
Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment.J Cell Biochem. 2004 Feb 15;91(3):459-77. doi: 10.1002/jcb.10747. J Cell Biochem. 2004. PMID: 14755677 Review.
-
Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells.Mol Endocrinol. 2004 Oct;18(10):2409-23. doi: 10.1210/me.2004-0117. Epub 2004 Jun 17. Mol Endocrinol. 2004. PMID: 15205473
-
Molecular genetics of prostate cancer.Ann Med. 2001 Mar;33(2):130-41. doi: 10.3109/07853890109002068. Ann Med. 2001. PMID: 11327116 Review.
-
Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases.Cancer Res. 2003 Jul 15;63(14):3886-90. Cancer Res. 2003. PMID: 12873978
-
Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer.Clin Cancer Res. 1999 Jun;5(6):1387-91. Clin Cancer Res. 1999. PMID: 10389923
Cited by
-
Patented prostate cancer biomarkers.Nat Rev Urol. 2012 Aug;9(8):464-72. doi: 10.1038/nrurol.2012.130. Epub 2012 Jul 3. Nat Rev Urol. 2012. PMID: 22750955 Review.
-
Genomics of prostate cancer: is there anything to "translate"?Pathol Oncol Res. 2005;11(4):197-203. doi: 10.1007/BF02893851. Epub 2005 Dec 31. Pathol Oncol Res. 2005. PMID: 16388315 Review.
-
Epigenetics of prostate cancer: beyond DNA methylation.J Cell Mol Med. 2006 Jan-Mar;10(1):100-25. doi: 10.1111/j.1582-4934.2006.tb00293.x. J Cell Mol Med. 2006. PMID: 16563224 Free PMC article. Review.
-
Akt1 mediates prostate cancer cell microinvasion and chemotaxis to metastatic stimuli via integrin β₃ affinity modulation.Br J Cancer. 2012 Aug 7;107(4):713-23. doi: 10.1038/bjc.2012.295. Epub 2012 Jul 5. Br J Cancer. 2012. PMID: 22767145 Free PMC article.
-
Precision Therapy for Prostate Cancer: Advancements in Polymeric Nanocarrier Systems.Anticancer Agents Med Chem. 2025;25(14):978-992. doi: 10.2174/0118715206360906241223120425. Anticancer Agents Med Chem. 2025. PMID: 39901538 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
